Denosumab Treatment for Giant Cell Tumor of Bone (GCTB) in Adolescent Patients: Interim Results From a Phase II Study

被引：0
|
作者：
Engellau, J. [1 ]
Chawla, S. [2 ]
Grimer, R. [3 ]
Powell, A. [4 ]
Schuetze, S. [5 ]
Skubitz, K. [6 ]
Staddon, A. [7 ]
Atchison, C. [8 ]
Zhao, Y. [8 ]
Jacobs, I. [8 ]
机构：
[1] Skane Univ Hosp, Lund, Sweden
[2] Sarcoma Oncol Ctr, Santa Monica, CA USA
[3] Royal Orthopaed Hosp, Birmingham B31 2AP, W Midlands, England
[4] Sir Charles Gairdner Hosp, Nedlands, WA 6009, Australia
[5] Univ Michigan, Ann Arbor, MI 48109 USA
[6] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
[7] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[8] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
32LBA
引用
收藏
页码：15 / 16
页数：5
相关论文
共 50 条
  • [41] Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
    Palmerini, Emanuela
    Seeger, Leanne L.
    Gambarotti, Marco
    Righi, Alberto
    Reichardt, Peter
    Bukata, Susan
    Blay, Jean-Yves
    Dai, Tian
    Jandial, Danielle
    Picci, Piero
    BMC CANCER, 2021, 21 (01)
  • [42] Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
    Emanuela Palmerini
    Leanne L. Seeger
    Marco Gambarotti
    Alberto Righi
    Peter Reichardt
    Susan Bukata
    Jean-Yves Blay
    Tian Dai
    Danielle Jandial
    Piero Picci
    BMC Cancer, 21
  • [43] Denosumab in Giant Cell Rich Tumors of Bone: An Open-Label Multicenter Phase II Study
    Lipplaa, Astrid
    Schreuder, Willem H.
    Pichardo, Sarina E. C.
    Gelderblom, Hans
    ONCOLOGIST, 2023, : E1005 - E1104
  • [44] Study of imaging changes following preoperative denosumab for giant cell tumor of bone
    Yang, Yongkun
    Xu, Hairong
    Liu, Weifeng
    Niu, Xiaohui
    JOURNAL OF BONE ONCOLOGY, 2022, 32
  • [45] Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases
    Deveci, Mehmet Ali
    Paydas, Semra
    Gonlusen, Gulfiliz
    Ozkan, Cenk
    Bicer, Omer Sunkar
    Tekin, Mustafa
    ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA, 2017, 51 (01) : 1 - 6
  • [46] Long-term treatment of giant cell tumors of bone (GCTB) with denosumab: a two institutions 8-year experience.
    Chawla, Neal Shiv
    Sudan, Madhuri
    Syed, Imran
    Chawla, Sant P.
    Ferrari, Stefano
    Picci, Piero
    Marchesi, Emanuela
    Leopardi, Martina Piccinni
    Sankhala, Kamalesh Kumar
    Parthasarathy, Prarthana
    Mendanha, William Esteves
    Paioli, Anna
    Daneshrad, Justin
    Palmerini, Emanuela
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [47] Is Treatment with Denosumab Associated with Local Recurrence in Patients with Giant Cell Tumor of Bone Treated with Curettage? A Systematic Review
    Tsukamoto, Shinji
    Tanaka, Yuu
    Mavrogenis, Andreas F.
    Kido, Akira
    Kawaguchi, Masahiko
    Errani, Costantino
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2020, 478 (05) : 1076 - 1085
  • [48] Clinical and pathological analysis of giant cell tumor of bone with denosumab treatment and local recurrence
    Hayashida, Kenta
    Kawabata, Yusuke
    Kato, Ikuma
    Kamiishi, Takayuki
    Matsuo, Kosuke
    Takeyama, Masanobu
    Inaba, Yutaka
    JOURNAL OF ORTHOPAEDIC SCIENCE, 2022, 27 (01) : 215 - 221
  • [49] Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
    Thomas, David
    Henshaw, Robert
    Skubitz, Keith
    Chawla, Sant
    Staddon, Arthur
    Blay, Jean-Yves
    Roudier, Martine
    Smith, Judy
    Ye, Zhishen
    Sohn, Winnie
    Dansey, Roger
    Jun, Susie
    LANCET ONCOLOGY, 2010, 11 (03) : 275 - 280
  • [50] Comparison of Denosumab and Zoledronic acid as neoadjuvant therapy in patients with giant cell tumor of bone
    Kanwat, Himanshu
    Banjara, Roshan
    Kumar, Venkatesan Sampath
    Majeed, Abdul
    Gamnagatti, Shivanand
    Khan, Shah Alam
    JOURNAL OF ORTHOPAEDIC SURGERY, 2021, 29 (02)
12345